v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Cash flows from operating activities:    
Net income $ 18,270 $ 30,147
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 24,813 25,151
Amortization of debt discount and deferred financing costs 792 770
Asset impairment 387 406
Deferred income tax expense (benefit) (6,377) 8,410
Stock based compensation expense 4,315 3,734
Losses (gains) on change in fair value of derivatives 776 (9,727)
Inventory adjustments 944 838
Other 799 1,227
Changes in operating assets and liabilities:    
Accounts receivable (416) (6,620)
Inventories (1,310) (4,570)
Operating lease right of use assets and lease liabilities 1,103 365
Other assets 3,585 1,875
Accounts payable 9,348 5,083
Deferred and unearned revenue 5,498 13,814
Other liabilities 11,537 (23,786)
Net cash provided by operating activities 74,064 47,117
Cash flows from investing activities:    
Purchase of property and equipment (27,721) (28,097)
Other 106 20
Net cash used for investing activities (27,615) (28,077)
Cash flows from financing activities:    
Repayments on long-term debt 0 (3)
Proceeds from issuance of common stock 493 1,820
Purchase of treasury stock (27,609) (10,649)
Payments on finance lease obligations (1,546) (1,109)
Net cash used for financing activities (28,662) (9,941)
Net change in cash, cash equivalents and restricted cash 17,787 9,099
Cash, cash equivalents and restricted cash, beginning of year 230,624 306,876
Cash, cash equivalents and restricted cash, end of period 248,411 315,975
Supplemental cash flow disclosure information:    
Cash paid for interest 459 2,322
Cash paid (received) for taxes 106 (127)
Capital expenditures accrued at the end of the period $ 7,634 $ 10,129